E-LIB Suche - Ergebnisse für: Agodoa, I.

1

P118: THE ROLE OF HEMOGLOBIN AND HEMOLYSIS ON TRANSCRANIAL ..:

Reggiani, G ; Coppadoro, B ; Munaretto, V...
HemaSphere. 6 (2022) - p. 26-27 , 2022

Link: https://doi.org/10.1097/..

2

Expérience en vie réelle du voxelotor dans la prise en char..:

Shah, N. ; Lipato, T. ; Alvarez, O....
La Revue de Médecine Interne. 43 (2022) - p. A201 , 2022

Link: https://doi.org/10.1016/..

3

Taux d'hémoglobine et complications chez les patients drépa..:

Ershler, W.B. ; De Castro, L.M. ; Pakbaz, Z....
La Revue de Médecine Interne. 43 (2022) - p. A202-A203 , 2022

Link: https://doi.org/10.1016/..

4

S268: SAFETY, TOLERABILITY, AND PHARMACOKINETIC/PHARMACODYN..:

Brown, C. ; Key, C. ; Agodoa, I....
HemaSphere. 6 (2022) - p. 169-170 , 2022

Link: https://doi.org/10.1097/..

5

PRO66 Health-Related Quality of Life in Persons with Sickle..:

Lanzkron, S. ; Crook, N. ; Wu, J....
Value in Health. 24 (2021) - p. S209-S210 , 2021

Link: https://doi.org/10.1016/..

6

Analysis of osteoporosis treatment patterns with bisphospho..:

LaFleur, J. ; DuVall, S.L. ; Willson, T....
Bone. 78 (2015) - p. 174-185 , 2015

Link: https://doi.org/10.1016/..

7

Validation of A Budget Impact Model For Use of Denosumab In..:

Mehta, D. ; Stolshek, B. ; Agodoa, I.
Value in Health. 18 (2015) 3 - p. A157 , 2015

Link: https://doi.org/10.1016/..

8

Denosumab: A cost-effective alternative for older men with ..:

Parthan, A. ; Kruse, M. ; Agodoa, I...
Bone. 59 (2014) - p. 105-113 , 2014

Link: https://doi.org/10.1016/..

9

Is Denosumab Cost-Effective Compared To Oral Bisphosphonate..:

Parthan, A. ; Kruse, M.M. ; Agodoa, I....
Value in Health. 16 (2013) 3 - p. A223 , 2013

Link: https://doi.org/10.1016/..

10

PMS40 Cost-Effectiveness of Denosumab for the Treatment of ..:

Parthan, A. ; Deflin, M.M. ; Agodoa, I....
Value in Health. 15 (2012) 7 - p. A446 , 2012

Link: https://doi.org/10.1016/..

11

Systematic review of the impact of erythropoiesis-stimulati..:

Johansen, K. L. ; Finkelstein, F. O. ; Revicki, D. A....
Nephrology Dialysis Transplantation. 27 (2011) 6 - p. 2418-2425 , 2011

Link: https://doi.org/10.1093/..

12

PCV29 Recent In-Hospital Mortality Trends Among Patients wi..:

Overbeek, J.A. ; Penning-Van Beest, F.J.A. ; Herings, R.M.C..
Value in Health. 14 (2011) 7 - p. A369 , 2011

Link: https://doi.org/10.1016/..

13

PCV30 Heart Failure (Re)Admissions in the Netherlands: Rate..:

Overbeek, J.A. ; Penning-van Beest, F.J.A. ; Herings, R.M.C..
Value in Health. 14 (2011) 7 - p. A369 , 2011

Link: https://doi.org/10.1016/..

14

Treatment satisfaction in postmenopausal women suboptimally..:

Palacios, S ; Agodoa, I ; Bonnick, S...
Palacios , S , Agodoa , I , Bonnick , S , van den Bergh , J , Ferreira , I , Ho , P R & Brown , J P 2015 , ' Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate ' , Journal of Clinical Endocrinology & Metabolism , vol. 100 , no. 3 , pp. E487-E492 . https://doi.org/10.1210/jc.2014-3594. , 2015

Link: https://cris.maastrichtu..

15

S268: SAFETY, TOLERABILITY, AND PHARMACOKINETIC/PHARMACODYN..:

C. Brown ; C. Key ; I. Agodoa...
http://journals.lww.com/10.1097/01.HS9.0000843964.45576.92. , 2022

Link: https://doi.org/10.1097/..